Quantitative Models in Life Science Business : From Value Creation to Business Processes / / edited by Jung Kyu Canci, Philipp Mekler, Gang Mu.

This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value r...

Full description

Saved in:
Bibliographic Details
Superior document:SpringerBriefs in Economics,
HerausgeberIn:
Place / Publishing House:Cham : : Springer International Publishing :, Imprint: Springer,, 2023.
Year of Publication:2023
Edition:1st ed. 2023.
Language:English
Series:SpringerBriefs in Economics,
Physical Description:1 online resource (IX, 127 p. 25 illus., 13 illus. in color.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04139nam a22006375i 4500
001 993573515204498
005 20230810175841.0
006 m o d
007 cr#nn#008mamaa
008 221116s2023 sz | o |||| 0|eng d
020 |a 3-031-11814-6 
024 7 |a 10.1007/978-3-031-11814-2  |2 doi 
035 |a (CKB)5710000000094996 
035 |a (DE-He213)978-3-031-11814-2 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/94992 
035 |a (MiAaPQ)EBC7141534 
035 |a (Au-PeEL)EBL7141534 
035 |a (OCoLC)1354208094 
035 |a (EXLCZ)995710000000094996 
040 |a MiAaPQ  |b eng  |e rda  |e pn  |c MiAaPQ  |d MiAaPQ 
041 0 |a eng 
050 4 |a RA410-410.9 
072 7 |a KCQ  |2 bicssc 
072 7 |a BUS069000  |2 bisacsh 
072 7 |a KCVJ  |2 thema 
082 0 4 |a 338.4761  |2 23 
100 1 |a Canci, Jung Kyu  |4 edt 
245 1 0 |a Quantitative Models in Life Science Business  |h [electronic resource] :  |b From Value Creation to Business Processes /  |c edited by Jung Kyu Canci, Philipp Mekler, Gang Mu. 
250 |a 1st ed. 2023. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2023. 
300 |a 1 online resource (IX, 127 p. 25 illus., 13 illus. in color.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a SpringerBriefs in Economics,  |x 2191-5512 
506 0 |a Open Access 
546 |a English 
505 0 |a Part I. Value Creation and Managing Intellectual Property in the Life Science Industry -- Chapter 1. Value Creation, Valuation and Business Models in the Pharmaceutical Sector -- Chapter 2. Alternative Licensing Strategies: A Piecewise Deterministic Differential Game -- Chapter 3. Partnership Models for R&D in the Pharmaceutical Industry -- Part II. Modelling Specific Business Processes in the Life Science Industry -- Chapter 4. Pharma Tender Processes: Modelling Auction Outcomes -- Chapter 5. Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning -- Part III. Specialized Quantitative Tools in the Life Science Industry -- Chapter 6. Stochastic Differential Equations in Healthcare -- Chapter 7. Point Processes with Mixed Doubly Stochastic Poisson and Self-Exciting Flavors: An Excursion Into DALY Computations. 
520 |a This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value realization in the life sciences as a sequence of processes using the quantitative language of applied mathematics. Written by experts from a variety of fields, the contributions illustrate the shift from a deterministic to a stochastic view of the processes involved, offering a new perspective on life sciences economics. The book covers topics such as valuing and managing intellectual property in life science, licensing in the pharmaceutical business, outsourcing pharmaceutical R&D, and stochastic modelling of a pharmaceutical supply chain. The book will appeal to scholars of economics and the life sciences, as well as to professionals in chemical and pharmaceutical industries. . 
650 0 |a Medical economics. 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Technological innovations. 
650 0 |a Medicine  |x Research. 
650 0 |a Biology  |x Research. 
650 0 |a Biotechnology. 
650 0 |a Econometrics. 
650 1 4 |a Health Economics. 
650 2 4 |a Pharmaceutics. 
650 2 4 |a Economics of Innovation. 
650 2 4 |a Biomedical Research. 
650 2 4 |a Biotechnology. 
650 2 4 |a Quantitative Economics. 
776 |z 3-031-11813-8 
700 1 |a Canci, Jung Kyu.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Mekler, Philipp.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Mu, Gang.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
830 0 |a SpringerBriefs in Economics,  |x 2191-5512 
906 |a BOOK 
ADM |b 2023-10-05 04:08:40 Europe/Vienna  |f system  |c marc21  |a 2022-12-03 21:34:07 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5341794030004498&Force_direct=true  |Z 5341794030004498  |b Available  |8 5341794030004498